Our expansive research facilities, state-of-the-art technologies and unique location within The Royal Children’s Hospital, are some of the reasons we’re home to over 1,800 leading researchers and scientists.
Discover how you can support us and our partners to help our researchers make life-changing breakthroughs for children.
Search throughout the entire MCRI website to find exactly what you are looking for.
Program area: Family Health & Wellbeing. Family Foundations is a family-based intervention that focuses on the critical early years of children’s lives and engages all parents/caregivers in the family. The study focuses on strengthening the skills needed to navigate stressful life circumstances
The Consortium’s vision is to facilitate and undertake Friedreich ataxia cell and gene therapy clinical trials leading to successful outcomes for patients as soon as possible. The Consortium is a strategic alliance of pre-eminent experts in Friedreich Ataxia, Stem Cells, Gene Therapy, Policy,
Advances in technology together with its increasing use and declining costs have opened up valuable opportunities for its application in healthcare.
To enhance the understanding of how an injury to a child’s brain can impact cognitive, behavioural, and social development.
This study is seeking to understand if a drug called Metformin can be used to improve thinking skills and promote white matter growth in children that have been previously treated for medulloblastoma.
Understanding how young people recover from concussion.
The BEST Trial aims to determine whether treatment of bone and joint infections in children with oral antibiotics alone is just as effective as treatment with intravenous antibiotics followed by an oral antibiotic course.
The Children’s Cancer Centre Biobank is a valuable collection of biological samples such as tissue collected during surgery, blood and bone marrow.
The Childhood to Adolescence Transition Study (CATS) is a unique longitudinal study following 1,200 Melbourne students from childhood through adolescence and into adulthood in metropolitan Melbourne. The study began in 2012 and recruited over 1,200 children from grade three (eight to nine years of
Using genomics and stem cell medicine to understand the causes of CHD and for the discovery of new treatments.
Page 126 of 205
